Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
To be determined,Cannabidiol with tetrahydrocannabinol,"Multiple sclerosis spasticity, epilepsy, pain and spasticity",Cannabidiol with tetrahydrocannabinol (Sativex),Recommended for decline,Community and Hospital,Nervous System
